- Engineering epigenetic HBV DNA modifiers containing DNA methyl transferases.
- Synthesis of chemically modified mRNA for use in treatment of chronic HBV infection.
- Next generation sequencing methods for the detection of off-target mutation by anti-HBV gene editors.
- Engineering of self-replicating anti-HBV mRNA vaccines.
- Incorporation of therapeutic nucleic acids into non-viral vectors comprising cyclodextrin conjugates with liver-targeting moieties.